The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Survival outcomes and immune correlates.
 
Alexandra Leary
Honoraria - Gerson Lehrman Group; Medscape; peervoice
Consulting or Advisory Role - Apmonia Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Seagen (Inst); Tesaro (Inst); zentalis (Inst)
Research Funding - Adaptimmune (Inst); AstraZeneca (Inst); Inivata (Inst); MSD Oncology (Inst); OSE Immunotherapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Laure Chardin
Research Funding - AstraZeneca
 
Alain Lortholary
Honoraria - AstraZeneca; clovis oncology; MSD; Novartis; Roche; Tesaro/GSK; Tesaro/GSK
 
Bernard Asselain
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo; Gilead Sciences; Pierre Fabre; Roche; SERVIER
 
Jerome Alexandre
Honoraria - AstraZeneca; Clovis Oncology; Eisai Europe; GlaxoSmithKline; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Eisaï; GlaxoSmithKline; Janssen Oncology; MSD Oncology; Seagen
Research Funding - GlaxoSmithKline (Inst); Janssen (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Eisai Europe; Janssen; Novartis
 
Coriolan Lebreton
Honoraria - Eisai; GlaxoSmithKline; MSD Oncology
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Aude-Marie Savoye
No Relationships to Disclose
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - AstraZeneca (Inst); Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche
 
Céline Gavoille
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Tesaro
Research Funding - Fujirebio
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Tesaro
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; Eisai; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); NOVARTIS (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Veronique D'hondt
Travel, Accommodations, Expenses - GlaxoSmithKline; Lilly; Pfizer
 
Julien Grenier
Honoraria - Daiichi Sankyo; Gilead Sciences
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Lilly
 
Elisa Yaniz-Galende
No Relationships to Disclose
 
Cyril Roussel-Simonin
No Relationships to Disclose
 
Thibault De La Motte Rouge
Honoraria - AstraZeneca; Gilead Sciences; GlaxoSmithKline; MSD Oncology; Mylan; Pfizer; Roche/Genentech; Sanofi; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; Eisai; Gilead Sciences; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Roche; Sanofi; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
 
Eric Pujade-Lauraine
Employment - Arcagy-Gineco
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AGENUS; AstraZeneca; Incyte; Merck; Roche
Research Funding - AstraZeneca (Inst)
Other Relationship - Arcagy-Gineco